A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1)

Inclusion Criteria: * Age ≥18 Years; * Male (weight ≥50kg) or female (weight ≥45kg); * BMI between 19\~28 kg/m2; * Healthy subjects (at screening); * Subject who totally understand the aim and progress of this clinical trial, make decision by his/her free will, and signed a consent form to follow the progress. Exclusion Criteria: * Allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator; * Subject who has past or present history of any serious diseases, including (but not limited to) digestive, cardiovascular, respiratory, urinary, musculoskeletal, endocrine, psychiatric or neurological, hematologic, immunological or metabolic disorders; * Medical examination, laboratory tests or ECG judged by the investigator to differ significantly from normal clinical values; * HIV, HBV, or syphilis positive; * Drug dependency or abuse; * Heavy smokers (\>5 cigarettes per day); * Alcohol use; * Participation in another study with an investigational drug within the last 3 months preceding this study; * Blood donation within the last 2 months (\>= 400 ml), or have a plan to donate blood within 1 month after this study; * Intake of any other drug which might influence the results of the trial during two weeks previous to the start of the study.